Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners. | Hell J Nucl Med;26(3): 166-171, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.

Koutelou, M; Prassopoulos, V; Lamprakos, L; Zissimopoulos, A; Chatzipanagiotou, T; Mastorakou, A; Doumas, A.

Affiliation

Koutelou M; Administrative board of the Hellenic Society of Nuclear Cardiology. adoumas@auth.gr.

Hell J Nucl Med ; 26(3): 166-171, 2023.

Article in En | MEDLINE | ID: mdl-38085831

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Heart Diseases / Amyloidosis / Nuclear Medicine Limits: Humans Language: En Journal: Hell J Nucl Med Journal subject: MEDICINA NUCLEAR Year: 2023 Document type: Article Country of publication: Grecia

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Heart Diseases / Amyloidosis / Nuclear Medicine Limits: Humans Language: En Journal: Hell J Nucl Med Journal subject: MEDICINA NUCLEAR Year: 2023 Document type: Article Country of publication: Grecia